Impact of Sacubitril/Valsartan on Cardiac Reverse Remodeling in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy. [PDF]
Atabekov T +5 more
europepmc +1 more source
Linking FHIR-Based Medication Data to a Computable Algorithm for Heart Medication Optimization: A Critical Component of Any Medication Learning Health System. [PDF]
LeGrand J +5 more
europepmc +1 more source
Efficacy of Sacubitril/Valsartan Among Heart Failure Individuals With Implanted Cardiac Defibrillators: A Systematic Review and Meta-Analysis. [PDF]
Asham H +5 more
europepmc +1 more source
Differential cardiovascular benefits of SGLT2 inhibitors, sacubitril/valsartan, omecamtiv mecarbil, and vericiguat across heart failure phenotypes: a systematic review and meta-analysis. [PDF]
Wang M, Zuo Z, Wu T, Zhou Z.
europepmc +1 more source
Efficacy and safety of sacubitril/valsartan combined with dapagliflozin in non-diabetic patients with advanced chronic kidney disease. [PDF]
Wang H, Li X, Jiang C, Liu X.
europepmc +1 more source
The Heart-Gut Axis in Heart Failure: The Role of Next-Generation Pharmacological Therapies. [PDF]
Salerno ENM +13 more
europepmc +1 more source
The Effect of Sacubitril/Valsartan on Mood and Cognitive Function in Patients with Heart Failure with Reduced Ejection Fraction. [PDF]
Al Kindi F +7 more
europepmc +1 more source
Sacubitril/valsartan as add-on to standard therapy in patients with heart failure: A randomized controlled trial. [PDF]
Dhawan R +6 more
europepmc +1 more source
Early Initiation of Sacubitril/Valsartan in Intracerebral Hemorrhage With Refractory Hypertension and Chronic Heart Failure: A Case Report. [PDF]
Nishino T +4 more
europepmc +1 more source
Pharmacokinetic and bioequivalence of two formulations of Valsartan/Amlodipine Tablet(I) in healthy Chinese volunteers: A randomized, three-period, partially replicated crossover study. [PDF]
Mei Y, Zuo X, Zhang T, Bu Z, Xu Z.
europepmc +1 more source

